| 1 |
|
The 3D organization of the nucleus and inheritance of epigenetic states
|
| 2 |
|
AAV
|
| 3 |
|
Accelerated atherosclerosis in autoimmune rheumatic diseases
|
| 4 |
|
Activation of gene expression by double-stranded RNA
|
| 5 |
|
Activation of PTK receptors in solid human tumors
|
| 6 |
|
Adaptor mediated activation of the Hsp100/ Clp protein ClpC controls general and regulatory proteolysis in Bacillus subtilis
|
| 7 |
|
Adjuvants and autoimmunity
|
| 8 |
|
Aging and evolutionary medicine
|
| 9 |
|
Agrobacterium tumefaciens
|
| 10 |
|
Alternative splicing and calcium ion channel diversity
|
| 11 |
|
Amino acid conjugation : contribution to the metabolism and toxicity of xenobiotic carboxylic acids
|
| 12 |
|
Amino acid synthesis in chloroplasts
|
| 13 |
|
AMP-activated protein kinase : regulating cellular and whole body energy balance
|
| 14 |
|
Amyloidosis : disease caused by amyloid
|
| 15 |
|
Analysis of protein-protein interaction, transcriptional regulation and metabolic networks
|
| 16 |
|
Analysis of SNP haplotypes
|
| 17 |
|
ANCA-associated systemic vasculitides
|
| 18 |
|
Anti-cytokine therapy in rheumatoid arthritis
|
| 19 |
|
Antibiotic inhibition of ribosome function
|
| 20 |
|
Antibiotic resistance and hospital-acquired infection
|
| 21 |
|
Antibiotics and antibiotic resistance
|
| 22 |
|
Antibiotics that target the 50S ribosomal subunit : resistance and other considerations
|
| 23 |
|
Antiphospholipid Syndrome (APS) : from pathogenesis to treatment
|
| 24 |
|
The antiphospholipid syndromes and variants in 2006 : the Catastrophic Antiphospholipid Syndrome ("CAPS") and the Microangiopathic Antiphospholipid Syndrome ("MAPS")
|
| 25 |
|
Apoptosis in C. elegans
|
| 26 |
|
Apoptosis in the immune system
|
| 27 |
|
Apoptosis in the nervous system
|
| 28 |
|
Apoptotic cell clearance deficiency
|
| 29 |
|
Apoptotic cell clearance deficiency
|
| 30 |
|
Apoptotic pathways in mammals
|
| 31 |
|
Array comparative genomic hybridisation to characterise copy number variation in the human genome
|
| 32 |
|
Arylamine N-acetyltransferases
|
| 33 |
|
Assembly of the 30S ribosomal subunit in vitro and in cells
|
| 34 |
|
Assembly of the photosynthesis apparatus
|
| 35 |
|
Assessing significance in genome-wide studies
|
| 36 |
|
Audience questions about evolution and medicine
|
| 37 |
|
Auto-antibodies as predictors of autoimmune disease
|
| 38 |
|
Autoimmune features in celiac disease
|
| 39 |
|
Autoimmunity and atherosclerosis
|
| 40 |
|
Autophagic cell death
|
| 41 |
|
Autophagy as a barrier to infection
|
| 42 |
|
Bacteria and virus evolution : a model for the study of natural selection
|
| 43 |
|
Bacterial activation of epithelial signaling
|
| 44 |
|
Bacterial extrachromosomal elements : role in chemical detoxification and potential cancer therapy
|
| 45 |
|
The bacterial pathogen Listeria monocytogenes : an amazing multifaceted model
|
| 46 |
|
Basic studies of protein folding and stability : the folding of related protein families
|
| 47 |
|
The Bcl-2 family
|
| 48 |
|
Biodefense challenges
|
| 49 |
|
Biodefense vaccines
|
| 50 |
|
The biogenesis of E. coli inner membrane proteins
|
| 51 |
|
The biogenesis of mitochondria in cancer
|
| 52 |
|
Biogenesis of the eukaryotic proteasome
|
| 53 |
|
The bioinformatics of microarrays
|
| 54 |
|
Bioinformatics tools in conservation biology
|
| 55 |
|
Biomarkers of exposure
|
| 56 |
|
Biomimetic catalysis
|
| 57 |
|
Bioorganic studies of vision
|
| 58 |
|
Bipolar spindle assembly
|
| 59 |
|
Bordetella pertussis
|
| 60 |
|
The bunyaviridae
|
| 61 |
|
Bunyaviruses
|
| 62 |
|
Ca(v)1.3 and deafness
|
| 63 |
|
Ca2+ signaling alterations in Alzheimer's disease
|
| 64 |
|
Ca2+, the endoplasmic reticulum and cardiac pathology
|
| 65 |
|
Calcium channelopathies
|
| 66 |
|
Calcium regulation of ion channels
|
| 67 |
|
Calcium regulation of transcription in plants
|
| 68 |
|
Calcium signaling and mitochondrial function
|
| 69 |
|
Cancer systems biology : dissection and analysis of context-specific molecular interaction networks
|
| 70 |
|
Capillaroscopy in autoimmune rheumatic diseases
|
| 71 |
|
Carotenoid functions and other isoprenoids in plants
|
| 72 |
|
The case for offering all women amniocentesis and chromosomal microarray analysis
|
| 73 |
|
Caspase inhibitors in drug discovery
|
| 74 |
|
Caspases
|
| 75 |
|
Catalytic cycle of cytochrome P450s
|
| 76 |
|
CD1d-restricted NKT cells : regulators of inflammation and autoimmunity
|
| 77 |
|
CD44 genetic deletion enhances and CD44 antibody targeting attenuates autoimmune inflammation
|
| 78 |
|
Cell cycle : a complex network of signals regulating cell proliferation
|
| 79 |
|
Cell cycle control by the ubiquitin system in mammals
|
| 80 |
|
Cell signalling pathways and RNAi
|
| 81 |
|
Cellular and molecular control of mating in male C. elegans
|
| 82 |
|
Cellular mechanisms of neuromodulation in a small neural network
|
| 83 |
|
Cellular signaling on host-malaria parasite interactions
|
| 84 |
|
Centrosome duplication and separation in animal cells
|
| 85 |
|
Chaperone mechanisms in cellular protein folding
|
| 86 |
|
Chaperone systems of the endoplasmic reticulum
|
| 87 |
|
Chaperones and prions
|
| 88 |
|
Chaperonin CCT mediated folding of actin, energetic landscapes and cell cycle control
|
| 89 |
|
Chemical protein synthesis : total synthesis of proteins for biological research / Stephen Kent
|
| 90 |
|
Chemical synthesis of peptides and peptide libraries
|
| 91 |
|
Chemistry of peptide bond formation
|
| 92 |
|
Chloroplast genetic engineering
|
| 93 |
|
The chloroplast genome and chloroplast gene expression
|
| 94 |
|
Chloroplast lipid biosynthesis
|
| 95 |
|
The chloroplast proteome
|
| 96 |
|
Cholera : a paradigm for understanding emergence, virulence and temporal patterns of disease
|
| 97 |
|
Chromatin and transcription
|
| 98 |
|
Chromatin architecture and the regulation of gene expression
|
| 99 |
|
Chromosome bi-orientation in yeast
|
| 100 |
|
Cleavage furrow formation and ingression during animal cytokinesis
|
| 101 |
|
Clinical importance of pharmacogenetic polymorphisms affecting drug metabolism : internal medicine
|
| 102 |
|
Clinical importance of pharmacogenetic polymorphisms affecting drug metabolism : psychopharmacology and pain
|
| 103 |
|
Clinical significance of enzyme induction and inhibition
|
| 104 |
|
ClpB : a chaperone for proteindisaggregation
|
| 105 |
|
CNVs in human genomes
|
| 106 |
|
The common origin for diverse autoimmune diseases
|
| 107 |
|
Complex DNA viruses : herpes virus
|
| 108 |
|
Computational methods in analysis of gene regulation and protein interactions
|
| 109 |
|
Control of growth : the Drosophila Myc homolog
|
| 110 |
|
Copy number variation
|
| 111 |
|
Copy number variation
|
| 112 |
|
Copy number variation and association studies
|
| 113 |
|
Copy number variation in association studies of human disease
|
| 114 |
|
Copy number variation in mental retardation
|
| 115 |
|
Copy number variation in neuropsychiatric disorders
|
| 116 |
|
Coupling transcription, RNA processing and RNA export
|
| 117 |
|
Covalently constrained alpha-helices
|
| 118 |
|
Crystal structures of drug-metabolizing P450 monooxygenases
|
| 119 |
|
CYP2 family
|
| 120 |
|
Cytochrome P450 1 family : the roles of 1A1, 1A2, & 1B1 in drug metabolism
|
| 121 |
|
Cytoplasmic epigenetics : inheritance by cytoplasmic continuity
|
| 122 |
|
Cytoplasmic epigenetics : proteins acting as genes
|
| 123 |
|
The dark side of amyloid : Pmel17, a natural amyloid in melanosome biogenesis
|
| 124 |
|
A Darwinian eye view of cancer
|
| 125 |
|
Databases for CNV in control and disease populations
|
| 126 |
|
The death receptor signaling pathway
|
| 127 |
|
Deciphering Shigella invasion of epithelial cells
|
| 128 |
|
Degradation of apoptotic cells
|
| 129 |
|
Dendritic cells
|
| 130 |
|
Dental pathogens
|
| 131 |
|
Design and engineering of zinc-finger domains
|
| 132 |
|
Designing a genome-wide association study
|
| 133 |
|
The development and function of vertebrate cilia
|
| 134 |
|
Developmental plasticity, evolution and the origins of disease
|
| 135 |
|
Diagnosis of early relapse in ovarian cancer : using serum proteomic profiling
|
| 136 |
|
Diagnostic methods in autoimmunity
|
| 137 |
|
Dicer and R2D2
|
| 138 |
|
Dimer catastrophes and plasmid resolution
|
| 139 |
|
Diseases of civilization : an evolutionary legacy
|
| 140 |
|
Disulfide bond formation in vivo
|
| 141 |
|
The diversity and evolution of ion channels
|
| 142 |
|
The diversity of bacterial conjugation and mobilization systems
|
| 143 |
|
The diversity of Escherichia coli infections
|
| 144 |
|
The DNA damage response
|
| 145 |
|
DNA methylation
|
| 146 |
|
DNA methylation
|
| 147 |
|
DNA methylation and genome defense in Neurospora crassa
|
| 148 |
|
DNA methylation and stem cells
|
| 149 |
|
DNA methylation as a tumor marker : implications for diagnosis, early detection and risk assessment
|
| 150 |
|
DNA methylation changes in aging cells and tissues
|
| 151 |
|
DNA methylation during development
|
| 152 |
|
DNA methylation in cancer
|
| 153 |
|
DNA methylation patterns in mammals
|
| 154 |
|
DNA processing in conjugative transfer
|
| 155 |
|
DNA replication
|
| 156 |
|
Drug discovery and target validation in the p53 pathway
|
| 157 |
|
Drug induced lupus and lupus-like syndromes
|
| 158 |
|
Drug metabolism in liver disease
|
| 159 |
|
Drug-DNA interactions of the mitomycins
|
| 160 |
|
Dynamic chromatin : ATP-dependent chromatin remodeling machines
|
| 161 |
|
The E2F family and transcriptional control of the mammalian cellcycle
|
| 162 |
|
Early nutrition, development and health : evolutionary perspectives on the metabolic syndrome
|
| 163 |
|
Ecogenetics : evolutionary biology and human disease
|
| 164 |
|
Editor's foreword
|
| 165 |
|
Effect of physiological factors and disease on drug metabolism
|
| 166 |
|
EGF receptor family : targets for cancer therapeutics
|
| 167 |
|
EGFR targeted therapies in lung cancer
|
| 168 |
|
Elongation of protein synthesis : structural basis of the peptide bond
|
| 169 |
|
Elongation of protein synthesis : structural basis of the process of decoding
|
| 170 |
|
Emerging respiratory viruses
|
| 171 |
|
The endocrinology of human life history transitions
|
| 172 |
|
The endoplasmic reticulum : the unfolded protein response
|
| 173 |
|
The endoplasmic reticulum as a calcium gateway in programmed cell death
|
| 174 |
|
The endoplasmic reticulum as a most efficient antibody factory
|
| 175 |
|
The endoplasmic reticulum in plants
|
| 176 |
|
Endoplasmic reticulum protein folding and control of calcium homeostasis
|
| 177 |
|
Endoplasmic reticulum stress in neurodegenerative diseases
|
| 178 |
|
Endoplasmic reticulum, protein synthesis and translocation machinery
|
| 179 |
|
Endothelial cell apoptosis
|
| 180 |
|
Endothelium and autoimmunity
|
| 181 |
|
Environmental effects on human reproduction
|
| 182 |
|
Environmental scleroderma : the evidence for external triggers
|
| 183 |
|
The Eph receptor family
|
| 184 |
|
The epidermal growth factor receptor family : roles in development and cancer
|
| 185 |
|
Epigenetic control by histone methylation
|
| 186 |
|
Epigenetic information in gene expression and cancer
|
| 187 |
|
Epigenetic regulation of phenotype
|
| 188 |
|
Epigenetically mediated gene silencing : a companion to genetic alterations in driving tumorigenesis
|
| 189 |
|
Epigenetics : a historical overview
|
| 190 |
|
Epigenomics of complex disease
|
| 191 |
|
The ERAD network
|
| 192 |
|
Ethical considerations in dealing with CNV information
|
| 193 |
|
Ethical issues in molecular epidemiology and studies of gene-environment interactions
|
| 194 |
|
Eukaryotic gene regulation : from chromatin to transcription to mRNA processing
|
| 195 |
|
Evolution : medicine's missing basicscience
|
| 196 |
|
Evolution and medicine : from the perspective of an evolutionary biologist
|
| 197 |
|
Evolution of innate immunity
|
| 198 |
|
Evolution of mammal epigenetic control systems
|
| 199 |
|
Evolution of plasmids and their role in bacterial diversity and adaptability
|
| 200 |
|
Evolution of virulence : malaria : a case study
|
| 201 |
|
Evolutionary and developmental variation in muscle mitochondrial content
|
| 202 |
|
Evolutionary arms races
|
| 203 |
|
Evolutionary behavioural genetics and mental disorders
|
| 204 |
|
Evolutionary biology of depression : depression is on a lumpy continum from low mood to clinical depression
|
| 205 |
|
Evolutionary considerations and the endothelium
|
| 206 |
|
The evolutionary ecology of immunity
|
| 207 |
|
Evolutionary genetic epidemiology
|
| 208 |
|
Evolutionary genetics : the detection of natural selection using molecular data
|
| 209 |
|
Evolutionary obstetrics
|
| 210 |
|
Evolving genomic approaches to the study of complex cardiovascular diseases in human populations : genetic and genomic epidemiology
|
| 211 |
|
Exploring and predicting phenotype and function in cancer biology : working in high dimensional data spaces
|
| 212 |
|
Extracellular calcium signaling
|
| 213 |
|
Extracellular proteostasis : an emerging field
|
| 214 |
|
Factor independent initiation of protein synthesis by IRES RNAs
|
| 215 |
|
Fast folding dynamics of small proteins : placing limits on diffusional limits
|
| 216 |
|
Fever and related defenses
|
| 217 |
|
Filoviruses
|
| 218 |
|
Folding and design of helical repeat proteins
|
| 219 |
|
From DNA to proteins : the multiple levels of regulation
|
| 220 |
|
From viruses to oncolytics
|
| 221 |
|
Function and regulation of the PDK1 kinase
|
| 222 |
|
The function of molecular chaperones in bacterial infection
|
| 223 |
|
Functional modules in ion channels
|
| 224 |
|
Functional roles of RNAi in C. elegans
|
| 225 |
|
The functions of the Hsp70 system
|
| 226 |
|
The G2/M transition
|
| 227 |
|
Gastroenteritis viruses
|
| 228 |
|
Gene and protein microarrays : tools for gene discovery and function
|
| 229 |
|
Gene by environment interaction in asthma
|
| 230 |
|
Gene copy number variation in human and primate evolution
|
| 231 |
|
Gene silencing by polycomb complexes
|
| 232 |
|
Gene-by-environment interaction : study designs and analytical methods
|
| 233 |
|
Gene-by-environment interactions in Chronic Obstructive Pulmonary Disease
|
| 234 |
|
General properties and applications of plasmids
|
| 235 |
|
Generation and propagation of infectious prions by cyclic amplification of protein misfolding
|
| 236 |
|
Genes in common diseases
|
| 237 |
|
Genetic and environmental triggers of autoimmune thyroid diseases
|
| 238 |
|
Genetic conflicts in human pregnancy
|
| 239 |
|
Genetic susceptibility in granulomatous disorders : chronic beryllium disease and sarcoidosis
|
| 240 |
|
Genetic variability in paraoxonase 1 (PON1), an HDL associated esterase : impact on risk and pharmacokinetics
|
| 241 |
|
Genetic variation and human disease
|
| 242 |
|
The genetics and biology of the [Het-s] prion of Podospora
|
| 243 |
|
Genome structure and expression
|
| 244 |
|
Genome-wide analyses of protein-DNA interactions
|
| 245 |
|
Genome-wide mapping of estrogen receptor binding sites and activity
|
| 246 |
|
Genome-wide profiling of microRNAs : from scientist benchside to patient bedside
|
| 247 |
|
Genomic disorders : mechanisms for copy number variation (CNV) and clinical implementation of high-resolution genome analysis
|
| 248 |
|
Genomic imprinting
|
| 249 |
|
Genomic imprinting : history and embryology
|
| 250 |
|
Genomic imprinting and its regulation
|
| 251 |
|
Genotyping algorithms for genome wide association studies
|
| 252 |
|
Geometric regulation of kinetochore orientation
|
| 253 |
|
Germ cells
|
| 254 |
|
GIS and spatial statistics
|
| 255 |
|
Global analysis of gene translation
|
| 256 |
|
Glucuronidation and the UDP - glucuronosyltransferases
|
| 257 |
|
Glutathione transferases
|
| 258 |
|
Glycan regulation of receptor functions
|
| 259 |
|
Glycobiology : an untapped source of novel drugs
|
| 260 |
|
Glycoprotein maturation and quality control in the endoplasmic reticulum
|
| 261 |
|
Glycosylation changes during oncogenesis
|
| 262 |
|
Glycosyltransferases : structures and mechanisms
|
| 263 |
|
GPI-anchored glycoproteins
|
| 264 |
|
Haemophilus
|
| 265 |
|
Hard tissue biology in human health and evolution
|
| 266 |
|
Health disparities in common, complex diseases : a role for genetics?
|
| 267 |
|
Hepatitis C and HCV
|
| 268 |
|
The HGF receptor : a targettable regulator of invasive growth
|
| 269 |
|
High resolution structure of ribosomal subunits : RNA/RNA and protein/RNA interactions
|
| 270 |
|
Histone dynamics, heritability and variants
|
| 271 |
|
Histone modification and transcriptional repression
|
| 272 |
|
Histone modifications and prospects for an epigenetic code
|
| 273 |
|
A historical perspective on ideas on X-chromosome inactivation
|
| 274 |
|
History of the molecular chaperone concept : roles in assembly processes
|
| 275 |
|
How aminoacyl-tRNA synthetases translate the genetic code
|
| 276 |
|
How do proteins fold and why?
|
| 277 |
|
How the PDGF receptor induces cell proliferation
|
| 278 |
|
How to design a successful microarray experiment
|
| 279 |
|
Hsp104 : a specialized chaperone for protein disaggregation
|
| 280 |
|
Hsp31 : a general stress protein of Escherichia coli
|
| 281 |
|
Hsp90 : a chaperone for protein kinases and hormone receptors
|
| 282 |
|
Human genetic variation and therapeutic development
|
| 283 |
|
Human genetics of infectious diseases : the example of bacterial / mycobacterial infections
|
| 284 |
|
Human genome variation
|
| 285 |
|
Human heat shock protein families
|
| 286 |
|
Human pathogenic Yersinia species
|
| 287 |
|
The hygiene hypothesis
|
| 288 |
|
Hypothalamic prolylcarboxpeptidase (PRCP) in the regulation of melanocortin system
|
| 289 |
|
Imatinib as a paradigm of targeted cancer therapies
|
| 290 |
|
The immunobiology of HIV
|
| 291 |
|
Immunodeficiencies and pathologies associated with mutations in STIM/ORAI
|
| 292 |
|
The impact of genomic architecture and diversity on human and infectious diseases
|
| 293 |
|
The importance of nucleotide size in the chemistry and biology of DNA
|
| 294 |
|
Imputing genotypes in genome-wide association studies
|
| 295 |
|
Indels, CNVs and the spectrum of human genome variation
|
| 296 |
|
Indians, twins and scleroderma : genetic and genomic studies
|
| 297 |
|
Infection and autoimmunity : a two-way relationship
|
| 298 |
|
Infection and chronic disease
|
| 299 |
|
Infectious environmental factors and systemic lupus erythematosus
|
| 300 |
|
Influenza virus pandemics : past and future
|
| 301 |
|
Information content in sequences and its relation to protein structure prediction
|
| 302 |
|
Initiation of DNA replication
|
| 303 |
|
Innate immunity and natural autoantibodies
|
| 304 |
|
Insertion sequences & DNA transposition
|
| 305 |
|
The interaction of antibiotics with the large ribosomal subunit from Haloarcula Marismortui
|
| 306 |
|
The interface of ecology and infection in fungal pathogens : sex and recombination in Cryptococcus
|
| 307 |
|
The interplay between protein phosphorylation and ubiquitylation in the NF-kB pathway
|
| 308 |
|
Intracellular DNA sensing pathways
|
| 309 |
|
Intravenous immunoglobulins : myth and reality
|
| 310 |
|
Intrinsically unstructured proteins : regulation and disease
|
| 311 |
|
Introduction to chromatin structure
|
| 312 |
|
Introduction to drug metabolism enzymes
|
| 313 |
|
Introduction to machine learning and its application in chemistry
|
| 314 |
|
Introduction to plasmid biology
|
| 315 |
|
Introduction to the ribosome : overview of protein synthesis on the ribosome
|
| 316 |
|
Invasion, metastasis and stem cells
|
| 317 |
|
Ion channel regulation by phosphorylation
|
| 318 |
|
KARAP/DAP12/TYROBP : three names and a multiplicity of biological functions in cellular interactions
|
| 319 |
|
KATP channels and insulin
|
| 320 |
|
The kinetochore as a target for the development of mitosis specific anti-cancer drugs
|
| 321 |
|
KV10.1 potassium channels in cancer
|
| 322 |
|
Laboratory methods for the in vitro study of drug metabolism
|
| 323 |
|
Left-right asymmetry in embryonic development : how epigenetic, biophysical forces and gene activity interplay to determine a major embryonic axis
|
| 324 |
|
Legionella pneumophila : an intracellular pathogen of phagocytes
|
| 325 |
|
Lipid metabolism and the endoplasmic reticulum
|
| 326 |
|
LKB1 pathway and its role in cancer
|
| 327 |
|
Lung biology and lung disease
|
| 328 |
|
Lysosomal cell death pathways : new possibilities for cancer therapy
|
| 329 |
|
M-current and its role in neuronal physiology
|
| 330 |
|
Macrophage heterogeneity in atherosclerosis regression
|
| 331 |
|
The macrophage mannose receptor
|
| 332 |
|
The macrophage mannose receptor
|
| 333 |
|
Mammalian microRNP assembly & function
|
| 334 |
|
Mapping motivations : evolutionary health promotion
|
| 335 |
|
Mapping small molecule binding sites with phage display technology
|
| 336 |
|
Mapping the molecular chaperone interaction network in yeast
|
| 337 |
|
Mechanical transmission or dissemination of infectious pathogens/parasties by arthropods
|
| 338 |
|
Mechanism of chaperone action of small heat shock proteins
|
| 339 |
|
Mechanism of prion generation in vitro
|
| 340 |
|
Mechanism of translocon function : current insights and models
|
| 341 |
|
The mechanisms and control of mRNA turnover in eukaryotic cells
|
| 342 |
|
Mechanisms of apoptosis from structural biology
|
| 343 |
|
Mechanisms of mitochondrial fusion and fission
|
| 344 |
|
Mechanisms of protein folding reactions
|
| 345 |
|
Mechanisms of RNAi : a molecular view or Argonaute : the secret life of slicer
|
| 346 |
|
Mechanisms of transcription : the eukaryotic pre-initiation complex
|
| 347 |
|
Mechanisms of yeast prion propagation
|
| 348 |
|
Mechanistic aspects and therapeutic applications of RNAi
|
| 349 |
|
Mechanistic aspects of chaperonin GroEL/ES function
|
| 350 |
|
Membrane transport from the endoplasmic reticulum
|
| 351 |
|
Mendelian CNV mutations
|
| 352 |
|
Mental disorders in the light of evolutionary biology
|
| 353 |
|
Meta-analysis in genome-wide association studies : application to type 2 diabetes
|
| 354 |
|
Methyltransferases
|
| 355 |
|
Microarrays : their design and use
|
| 356 |
|
Microarrays in the study of the basic mechanisms of evolution
|
| 357 |
|
Microbial recognition and the immune response
|
| 358 |
|
MicroRNA biogenesis
|
| 359 |
|
Mitochondria in apoptosis
|
| 360 |
|
Mitochondrial biogenesis as a result of exercise
|
| 361 |
|
Mitochondrial biogenesis during gametogenesis and embryonic development
|
| 362 |
|
Mitochondrial chaperonin Hsp60 : locations, functions and pathology
|
| 363 |
|
Mitochondrial complex assembly
|
| 364 |
|
Mitochondrial diseases : an update
|
| 365 |
|
Mitochondrial disorders and neurodegeneration
|
| 366 |
|
Mitochondrial DNA replication and transcription
|
| 367 |
|
Mitochondrial heterogeneity in cells
|
| 368 |
|
Mitochondrial myopathies : exercise and nutrition
|
| 369 |
|
The mitochondrial pathway of apoptosis
|
| 370 |
|
Mitochondrial permeability transition
|
| 371 |
|
Mitochondrial phospholipid synthesis and incorporation
|
| 372 |
|
Mitotic chromosome condensation
|
| 373 |
|
Modular protein-protein interactions provide a general mechanism to organize dynamic cellular systems
|
| 374 |
|
The molecular basis of bacterial pathogenicity : an overview
|
| 375 |
|
The molecular basis of insulin action
|
| 376 |
|
Molecular chaperones and handling of abnormal proteins in neurodegenerative disorders
|
| 377 |
|
Molecular dynamics simulations of protein dynamics, unfolding and misfolding
|
| 378 |
|
Molecular epidemiology and evolutionary genetics of pathogens
|
| 379 |
|
Molecular epidemiology of lung cancer
|
| 380 |
|
Molecular pathogenesis and prevention of Staphylococcus aureus infections
|
| 381 |
|
Molecular structure of amyloid and prion fibrils : insights from solid state NMR
|
| 382 |
|
Mononuclear phagocytes : origins, fates and functions
|
| 383 |
|
Mouse models to investigate cell cycle and cancer
|
| 384 |
|
mRNA capping
|
| 385 |
|
Muscle mitochondrial function and biogenesis with aging
|
| 386 |
|
Natural caspase inhibitors
|
| 387 |
|
Natural history and pathogenesis of herpesvirus infections
|
| 388 |
|
Negative regulation of RTKs : receptor ubiquitylation, endocytosis and feedback loops
|
| 389 |
|
Network motifs : basic building blocks of biological networks
|
| 390 |
|
New designs for siRNAs as Dicer-substrates
|
| 391 |
|
A new frontier in biology : deciphering the molecular language of symbiosis
|
| 392 |
|
Nociception and ₀ł2₀þ3
|
| 393 |
|
Non HIV anti virals
|
| 394 |
|
Non-P450 oxidative metabolism : characteristics and drug substrates
|
| 395 |
|
Nonsense-mediated and Staufen1-mediated mRNA decay : related pathways of post-transcriptional control in mammalian cells
|
| 396 |
|
Novel approaches to diagnosis of viral infections
|
| 397 |
|
Novel aspects of systemic sclerosis : autoimmune diseases: advances in diagnostic methodologies
|
| 398 |
|
Novel proteins from designed combinatorial libraries
|
| 399 |
|
Nuclear cloning, stem cells and epigenetic reprogramming : the promise for "customized" tissue repair
|
| 400 |
|
Nuclear control of respiratory chain expression by transcriptional activators and coactivators
|
| 401 |
|
Nuclear organization and gene expression
|
| 402 |
|
Nuclear protein quality control degradation
|
| 403 |
|
Nucleosome assembly during DNA replication
|
| 404 |
|
Nucleosome dynamics and remodeling
|
| 405 |
|
Nucleotide dependent functioning of bacterial enhancer binding proteins, activators of sigma54 RNA polymerase
|
| 406 |
|
Occupational and environmental influences on the development and course of lupus
|
| 407 |
|
Origin and molecular evolution of the plastid
|
| 408 |
|
Origin of myeloid cells
|
| 409 |
|
The original human diet : what was it? : Should it be a model for contemporary nutrition?
|
| 410 |
|
Overview of eukaryotic molecular chaperones in the cytosol
|
| 411 |
|
Overview of prokaryotic molecular chaperones
|
| 412 |
|
p53 and apoptosis
|
| 413 |
|
The p53 family : function & molecular mechanisms
|
| 414 |
|
The paleolithic lifestyle and prevention of chronic disease
|
| 415 |
|
Papillomaviruses and HPV vaccination to prevent cervical cancer and other HPV-associated diseases
|
| 416 |
|
Parasite transmission by arthropods
|
| 417 |
|
The past, present and future of vaccination
|
| 418 |
|
Pathogenic mechanisms of autoantibodies
|
| 419 |
|
Pathways of apoptosis in muscle
|
| 420 |
|
Pattern discovery in bioinformatics
|
| 421 |
|
The pCF10-encoded pheromone response : cell-cell signaling, complexity and evolution
|
| 422 |
|
Perspectives in biological catalysis
|
| 423 |
|
Phagocytosis of apoptotic cells
|
| 424 |
|
Pharmacogenetics of the P450
|
| 425 |
|
Phospholipase C Gamma
|
| 426 |
|
Phosphoserine/threonine binding domains : molecular integrators of protein kinase signaling in cell cycle control and cancer
|
| 427 |
|
Photosynthesis : carbon assimilation
|
| 428 |
|
Photosynthesis : energy capture
|
| 429 |
|
Physiology and pathophysiology of the calcium store in the endoplasmic reticulum of neurones
|
| 430 |
|
PI 3-Kinase signalling enzymes & lipid messengers
|
| 431 |
|
PI3K/AKT signaling in cancer
|
| 432 |
|
Pigments : chlorophyll and its synthesis
|
| 433 |
|
Plasmid rolling-circle (RC) replication
|
| 434 |
|
Plasmid segregation and stability in bacteria
|
| 435 |
|
Plasmid stabilization by cell killing
|
| 436 |
|
Plasmids : copy number control by antisense RNAs
|
| 437 |
|
Plasmids, integrons and the spread of antibiotic resistance
|
| 438 |
|
Plastid senescence
|
| 439 |
|
Plastid structure : development and differentiation
|
| 440 |
|
Polyadenylation of mRNA precursors : mechanism, regulation and connections with other cellularprocesses
|
| 441 |
|
Polycomb epigenetic mechanisms
|
| 442 |
|
Polydactyl zinc finger proteins : software and hardware for genomes
|
| 443 |
|
Population genetic studies in Africa : curiosity and challenges
|
| 444 |
|
Population genetics considerations
|
| 445 |
|
Population genetics of structural variation
|
| 446 |
|
Population structure in genome-wide association studies : detection and correction
|
| 447 |
|
Population-specific evolution of natural killer cell diversity
|
| 448 |
|
Possible roles of mitochondrial biogenesis in aging
|
| 449 |
|
Poxviruses : Smallpox (variola), Vaccinia and Monkeypox
|
| 450 |
|
The pRB/E2F pathway
|
| 451 |
|
Pre-mRNA splicing
|
| 452 |
|
Predicting TSE transmission
|
| 453 |
|
Prediction and design of protein structures and interactions
|
| 454 |
|
Prediction of pathways of drug metabolism : in silico approaches
|
| 455 |
|
Pregnancy in autoimmune rheumatic diseases
|
| 456 |
|
Preventing varicella and zoster by vaccination
|
| 457 |
|
The principle of translation
|
| 458 |
|
Principles of virology I
|
| 459 |
|
Principles of virology II
|
| 460 |
|
Prion diseases
|
| 461 |
|
Prions and amyloids : introduction
|
| 462 |
|
Probing protein-protein interactions with peptide libraries andarrays
|
| 463 |
|
Propagation and variability of the yeast [PSI+] prion
|
| 464 |
|
Protective autoimmunity
|
| 465 |
|
Protein aggregation, metals and oxidative stress in neurodegenerative diseases
|
| 466 |
|
Protein degradation
|
| 467 |
|
Protein folding
|
| 468 |
|
Protein folding and dynamics from single molecule spectroscopy
|
| 469 |
|
Protein folding and misfolding : from theory to therapy
|
| 470 |
|
Protein folding in vivo
|
| 471 |
|
Protein folding inside the cell : macromolecular crowding and protein aggregation
|
| 472 |
|
Protein homeostasis and the chaperone interaction network in Arabidopsis thaliana
|
| 473 |
|
Protein homeostasis in mitochondria : AAA+ chaperones & proteases
|
| 474 |
|
Protein homeostasis in mitochondria : chaperones and proteases of the mitochondrial matrix
|
| 475 |
|
Protein import into chloroplasts
|
| 476 |
|
Protein import into mitochondria
|
| 477 |
|
Protein kinase structure, function and regulation
|
| 478 |
|
Protein networks and analysis of global gene expression
|
| 479 |
|
Protein phosphorylation and the control of protein synthesis
|
| 480 |
|
Protein synthesis in plastids
|
| 481 |
|
Protein tyrosine phosphatases
|
| 482 |
|
Protein-glycan interactions
|
| 483 |
|
Protein-protein interaction networks
|
| 484 |
|
Proteins that bind methylated DNA
|
| 485 |
|
Pulmonary hypertension in the connective tissue diseases pathogenesis : clinical features and therapeutic options in 2006
|
| 486 |
|
Quality control measures for GWAS
|
| 487 |
|
Quantitative CNV testing in molecular diagnostics
|
| 488 |
|
Quantitative genetics and multifactorial inheritance
|
| 489 |
|
Quantitative proteomics
|
| 490 |
|
Race in genetics and medicine
|
| 491 |
|
Racial and ethnic variation in systemic lupus erythematosus and systemic sclerosis (Scleroderma)
|
| 492 |
|
Reactive oxygen species and myocardial apoptosis
|
| 493 |
|
Receptor identification for alarmins and DAMPs
|
| 494 |
|
Receptor tyrosine kinases : function, families and evolution
|
| 495 |
|
Recoding : getting more out of the message by shifting reading frame and redefining codon meaning
|
| 496 |
|
Recognition of "self" and "non-self" glycans by carbohydrate-binding proteins : structural and functionalaspects
|
| 497 |
|
The recognition of misfolded glycoproteins in the endoplasmic reticulum
|
| 498 |
|
The recognition of pathogens by C-type lectins
|
| 499 |
|
The recognition of pathogens by C-type lectins
|
| 500 |
|
Recombination and the formation of chiasmata in meiosis
|
